ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 184 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $165,000 | -22.5% | 2,744 | +8.9% | 0.00% | -25.0% |
| Q2 2019 | $213,000 | -11.6% | 2,520 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $241,000 | +35.4% | 2,520 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $178,000 | -17.2% | 2,520 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $215,000 | +7.0% | 2,520 | +45.2% | 0.00% | 0.0% |
| Q2 2018 | $201,000 | +43.6% | 1,736 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $140,000 | +636.8% | 1,736 | +210.0% | 0.00% | +200.0% |
| Q4 2016 | $19,000 | – | 560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,599,109 | $63,277,000 | 8.68% |
| SENZAR ASSET MANAGEMENT, LLC | 566,903 | $22,432,000 | 6.58% |
| Sarissa Capital Management LP | 105,000 | $4,155,000 | 1.60% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 136,637 | $5,407,000 | 1.41% |
| RA Capital Management | 250,000 | $9,893,000 | 1.17% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 110,515 | $4,373,000 | 0.99% |
| Ghost Tree Capital, LLC | 35,000 | $1,385,000 | 0.75% |
| WALL STREET ASSOCIATES | 159,100 | $6,296,000 | 0.65% |
| BAILARD, INC. | 91,500 | $3,621,000 | 0.56% |
| EAM Investors, LLC | 62,768 | $2,484,000 | 0.50% |